The FDA has approved the balloon-expandable Sapien 3 TAVR platform from Edwards Lifesciences for treating asymptomatic severe aortic stenosis. This is the first time the agency has approved any TAVR technology to be used in asymptomatic patients. 

This is the first randomized controlled trial to compare the use of ultrasound energy-based focal ablation to robot-assisted radical prostatectomy. 

The study's authors reviewed CCTA imaging results taken before and after radiotherapy, evaluating each image for signs of coronary calcification and inflammation. 

New research may help providers identify patterns on neuroimaging that could offer clues into how well patients are responding to antidepressant medications.

An advanced preservation system from Paragonix, a Getinge company, was linked to dramatic reductions in both mortality and procedural complications. 

Patient outcomes do not appear to be negatively impacted by these risks, researchers noted. The new data were presented at Heart Rhythm 2025 and published in JACC: Clinical Electrophysiology.

Many have touted smoking marijuana as a safer alternative to cigarettes. New imaging data offer clarity on whether this notion is actually true. 

Researchers explored the potential impact of more than 100 risk factors on a person's risk of sudden cardiac arrest. Some of their findings were what you may expect, but others were much more surprising.